{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:59:07Z","timestamp":1772765947784,"version":"3.50.1"},"reference-count":153,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"American University of Beirut Faculty of Medicine","award":["#320148"],"award-info":[{"award-number":["#320148"]}]},{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund, Egypt","doi-asserted-by":"crossref","award":["14895"],"award-info":[{"award-number":["14895"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.phrs.2017.11.029","type":"journal-article","created":{"date-parts":[[2017,11,26]],"date-time":"2017-11-26T22:47:59Z","timestamp":1511736479000},"page":"251-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Cardiovascular and renal interactions between cyclosporine and NSAIDs: Underlying mechanisms and clinical relevance"],"prefix":"10.1016","volume":"129","author":[{"given":"Ahmed F.","family":"El-Yazbi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali H.","family":"Eid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud M.","family":"El-Mas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2017.11.029_bib0005","first-page":"631","article-title":"Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity","volume":"31","author":"Borel","year":"1976","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2017.11.029_bib0010","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0162-3109(00)00192-2","article-title":"Mechanisms of action of cyclosporine","volume":"47","author":"Matsuda","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.phrs.2017.11.029_bib0015","first-page":"986","article-title":"Cyclosporin in cadaveric renal transplantation: one-year follow-up of a multicentre trial","volume":"2","year":"1983","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.phrs.2017.11.029_bib0020","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1146\/annurev.me.37.020186.001243","article-title":"Action and toxicity of cyclosporine","volume":"37","author":"Bennett","year":"1986","journal-title":"Annu. Rev. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.phrs.2017.11.029_bib0025","first-page":"S1","article-title":"KDIGO clinical practice guideline for the care of kidney transplant recipients","volume":"9","year":"2009","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.phrs.2017.11.029_bib0030","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.4254\/wjh.v7.i10.1355","article-title":"Review on immunosuppression in liver transplantation","volume":"7","author":"Moini","year":"2015","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2174\/157340311797484286","article-title":"Postoperative care of the transplanted patient","volume":"7","author":"Schumacher","year":"2011","journal-title":"Curr. Cardiol. Rev."},{"key":"10.1016\/j.phrs.2017.11.029_bib0040","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.healun.2010.05.034","article-title":"The International Society of Heart and Lung Transplantation Guidelines for the care of heart transplant recipients","volume":"29","author":"Costanzo","year":"2010","journal-title":"J. Heart Lung Transplant."},{"key":"10.1016\/j.phrs.2017.11.029_bib0045","first-page":"1039","article-title":"Immunosuppression in lung transplantation","volume":"6","author":"Scheffert","year":"2014","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.phrs.2017.11.029_bib0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1053\/j.seminhematol.2012.07.004","article-title":"Immunomodulatory treatment of myelodysplastic syndromes: antithymocyte globulin, cyclosporine, and alemtuzumab","volume":"49","author":"Parikh","year":"2012","journal-title":"Semin. Hematol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0055","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1586\/ecp.10.31","article-title":"Second-line options for refractory steroid-sensitive and -resistant nephrotic syndrome","volume":"3","author":"Oh","year":"2010","journal-title":"Exp. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0060","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1155\/2013\/805705","article-title":"Cyclosporine regimens in plaque psoriasis: an overview with special emphasis on dose, duration, and old and new treatment approaches","volume":"2013","author":"Colombo","year":"2013","journal-title":"Sci. World J."},{"key":"10.1016\/j.phrs.2017.11.029_bib0065","first-page":"397","article-title":"Cyclosporine A in the long-term management of systemic lupus erythematosus","volume":"25","author":"Germano","year":"2011","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.phrs.2017.11.029_bib0070","article-title":"Cyclosporine for rheumatoid arthritis","author":"Wells","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2017.11.029_bib0075","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1177\/0961203311400113","article-title":"Chronic polyarthritis as the first manifestation of juvenile systemic lupus erythematosus patients","volume":"20","author":"Cavalcante","year":"2011","journal-title":"Lupus"},{"key":"10.1016\/j.phrs.2017.11.029_bib0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0008-6363(00)00052-3","article-title":"Influence of cyclosporine A on contractile function, calcium handling, and energetics in isolated human and rabbit myocardium","volume":"47","author":"Janssen","year":"2000","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0085","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/BF02550970","article-title":"Acute cardiovascular effects of intravenous cyclosporine","volume":"28","author":"Navarro","year":"1996","journal-title":"Int. Urol. Nephrol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0090","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/jlts.2002.34381","article-title":"Cardiac function after orthotopic liver transplantation and the effects of immunosuppression: a prospective randomized trial comparing cyclosporin (Neoral) and tacrolimus","volume":"8","author":"Therapondos","year":"2002","journal-title":"Liver Transpl."},{"key":"10.1016\/j.phrs.2017.11.029_bib0095","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1124\/jpet.301.1.346","article-title":"Cyclosporine adversely affects baroreflexes via inhibition of testosterone modulation of cardiac vagal control","volume":"301","author":"El-Mas","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.11.029_bib0100","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1139\/y02-084","article-title":"Cyclosporine attenuates the autonomic modulation of reflex chronotropic responses in conscious rats","volume":"80","author":"El-Mas","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ejphar.2012.08.021","article-title":"Redox imbalances incite the hypertensive, baroreflex, and autonomic effects of cyclosporine in rats","volume":"694","author":"El-Mas","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0110","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1373\/clinchem.2011.167296","article-title":"Molecular diagnostics of calcineurin-related pathologies","volume":"58","author":"Musson","year":"2012","journal-title":"Clin. Chem."},{"key":"10.1016\/j.phrs.2017.11.029_bib0115","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11906-012-0274-7","article-title":"Nonsteroidal antiinflammatory drugs, acetaminophen, and hypertension","volume":"14","author":"Sudano","year":"2012","journal-title":"Curr. Hypertens. Rep."},{"key":"10.1016\/j.phrs.2017.11.029_bib0120","doi-asserted-by":"crossref","first-page":"c7086","DOI":"10.1136\/bmj.c7086","article-title":"Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis","volume":"342","author":"Trelle","year":"2011","journal-title":"BMJ (Clin. Res. Ed.)"},{"key":"10.1016\/j.phrs.2017.11.029_bib0125","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1734-1140(10)70310-8","article-title":"NSAIDs and cardiovascular disease: transducing human pharmacology results into clinical read-outs in the general population","volume":"62","author":"Capone","year":"2010","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.phrs.2017.11.029_bib0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1517\/14740330903311023","article-title":"Renal adverse effects of nonsteroidal anti-inflammatory drugs","volume":"8","author":"Harirforoosh","year":"2009","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.phrs.2017.11.029_bib0135","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/pds.3890","article-title":"Risks of hypertension associated with cyclosporine, nonsteroidal anti-inflammatory drugs, and systemic glucocorticoids in patients with psoriasis: a nationwide population-based nested case-control study in Taiwan","volume":"25","author":"Lee","year":"2016","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.phrs.2017.11.029_bib0140","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","article-title":"Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney","volume":"34","author":"Norregaard","year":"2015","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.phrs.2017.11.029_bib0145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.5049\/EBP.2008.6.1.35","article-title":"Renal effects of prostaglandins and cyclooxygenase-2 inhibitors","volume":"6","author":"Kim","year":"2008","journal-title":"Electrolytes Blood Press."},{"key":"10.1016\/j.phrs.2017.11.029_bib0150","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1146\/annurev.physiol.70.113006.100614","article-title":"Physiological regulation of prostaglandins in the kidney","volume":"70","author":"Hao","year":"2008","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0155","first-page":"F219","article-title":"Cyclooxygenase inhibitors increase Na-K-2Cl cotransporter abundance in thick ascending limb of Henle's loop","volume":"277","author":"Fernandez-Llama","year":"1999","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0160","first-page":"457","article-title":"Drug-induced impairment of renal function","volume":"7","author":"Pazhayattil","year":"2014","journal-title":"Int. J. Nephrol. Renovasc. Dis."},{"key":"10.1016\/j.phrs.2017.11.029_bib0165","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/ph3041279","article-title":"Significant acute kidney injury due to non-steroidal anti-inflammatory drugs: inpatient setting","volume":"3","author":"Dixit","year":"2010","journal-title":"Pharmaceuticals (Basel, Switzerland)"},{"key":"10.1016\/j.phrs.2017.11.029_bib0170","first-page":"204","article-title":"Chronic cyclosporine-associated nephrotoxicity","volume":"18","author":"Porter","year":"1986","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.phrs.2017.11.029_bib0175","first-page":"213","article-title":"Enhancement of cyclosporine A nephrotoxicity by diclofenac","volume":"27","author":"Deray","year":"1987","journal-title":"Clin. Nephrol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0180","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/0002-9343(92)90169-C","article-title":"Interaction of cyclosporine A and nonsteroidal anti-inflammatory drugs on renal function in patients with rheumatoid arthritis","volume":"93","author":"Altman","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.phrs.2017.11.029_bib0185","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/00004872-199408000-00009","article-title":"Indomethacin and cyclosporin together produce marked renal vasoconstriction in humans","volume":"12","author":"Sturrock","year":"1994","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.11.029_bib0190","first-page":"141","article-title":"Interaction of cyclosporine and indomethacin in the rat","volume":"61","author":"Williamson","year":"1988","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0195","doi-asserted-by":"crossref","first-page":"471","DOI":"10.2165\/00002018-199921060-00004","article-title":"Immunosuppressant-induced nephropathy: pathophysiology, incidence and management","volume":"21","author":"Olyaei","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.phrs.2017.11.029_bib0200","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1038\/ki.1985.196","article-title":"Effect of cyclosporine administration on renal hemodynamics in conscious rats","volume":"28","author":"Murray","year":"1985","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2017.11.029_bib0205","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1042\/cs0810271","article-title":"Influence of nifedipine on cyclosporin A nephrotoxicity after unilateral nephrectomy in the spontaneously hypertensive rat","volume":"81","author":"McNally","year":"1991","journal-title":"Clin. Sci. (London, England: 1979)"},{"key":"10.1016\/j.phrs.2017.11.029_bib0210","doi-asserted-by":"crossref","first-page":"167","DOI":"10.33549\/physiolres.933332","article-title":"Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension","volume":"66","author":"Hoskova","year":"2017","journal-title":"Physiol. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0215","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.brainres.2008.11.008","article-title":"Interruption of central neuronal pathway of imidazoline I1 receptor mediates the hypertensive effect of cyclosporine in rats","volume":"1248","author":"El-Mas","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0220","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.neuropharm.2011.12.017","article-title":"Crosstalk between central pathways of nitric oxide and carbon monoxide in the hypertensive action of cyclosporine","volume":"62","author":"El-Mas","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.phrs.2017.11.029_bib0225","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00210-014-1074-1","article-title":"Central modulation of cyclosporine-induced hypertension","volume":"388","author":"El-Gowelli","year":"2015","journal-title":"Naunyn-Schmiedeberg Arch. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0230","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0895-7061(00)00288-0","article-title":"Calcineurin inhibitors cause renal afferent activation in rats: a novel mechanism of cyclosporine-induced hypertension","volume":"13","author":"Zhang","year":"2000","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.phrs.2017.11.029_bib0235","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1073\/pnas.170160397","article-title":"Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings","volume":"97","author":"Zhang","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.phrs.2017.11.029_bib0240","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10557-004-6223-1","article-title":"Time-domain evaluation of cyclosporine interaction with hemodynamic variability in rats","volume":"18","author":"Omar","year":"2004","journal-title":"Cardiovasc. Drugs Therapy"},{"key":"10.1016\/j.phrs.2017.11.029_bib0245","doi-asserted-by":"crossref","first-page":"H1462","DOI":"10.1152\/ajpheart.00245.2013","article-title":"Cyclooxygenase-1 inhibition attenuates angiotensin II-salt hypertension and neurogenic pressor activity in the rat","volume":"305","author":"Asirvatham-Jeyaraj","year":"2013","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0250","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuroscience.2010.07.051","article-title":"Cyclooxygenase and nitric oxide synthase in the presympathetic neurons in the paraventricular hypothalamic nucleus are involved in restraint stress-induced sympathetic activation in rats","volume":"170","author":"Yamaguchi","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2017.11.029_bib0255","first-page":"57","article-title":"Spectral heart rate variability in rats with cyclophosphamide-induced hemorrhagic cystitis treated with cyclooxygenase inhibitors","volume":"55","author":"Dobrek","year":"2015","journal-title":"Folia Med. Cracov."},{"key":"10.1016\/j.phrs.2017.11.029_bib0260","first-page":"21","article-title":"Prostaglandin-targeting agents and spectral heart rate variability in experimental partial bladder outlet obstruction in rats","volume":"103","author":"Dobrek","year":"2016","journal-title":"Physiol. Int."},{"key":"10.1016\/j.phrs.2017.11.029_bib0265","first-page":"497","article-title":"The influence of piroxicam, a non-selective cyclooxygenase inhibitor, on autonomic nervous system activity in experimental cyclophosphamide-induced hemorrhagic cystitis and bladder outlet obstruction in rats","volume":"71","author":"Dobrek","year":"2014","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.phrs.2017.11.029_bib0270","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1111\/j.1523-1755.1998.00852.x","article-title":"Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats","volume":"53","author":"Cavarape","year":"1998","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2017.11.029_bib0275","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ejphar.2014.05.046","article-title":"Endothelin ETA receptor antagonism in cardiovascular disease","volume":"737","author":"Nasser","year":"2014","journal-title":"Eur. J. Pharmacol."},{"issue":"Suppl. 7","key":"10.1016\/j.phrs.2017.11.029_bib0280","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1097\/00005344-199100177-00048","article-title":"Comparative effects of cyclosporine A and FK-506 on endothelin secretion by a cultured renal cell line, LLC-PK1","volume":"17","author":"Nakahama","year":"1991","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0285","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3109\/08860229209106641","article-title":"Endothelin and cyclosporine nephrotoxicity","volume":"14","author":"Kon","year":"1992","journal-title":"Ren. Fail."},{"key":"10.1016\/j.phrs.2017.11.029_bib0290","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1399-0012.2005.00357.x","article-title":"Endothelin-1 plasma levels and hypertension in cyclosporine-treated renal transplant patients","volume":"19","author":"Cauduro","year":"2005","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.phrs.2017.11.029_bib0295","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1161\/01.HYP.26.6.932","article-title":"Effects of an endothelin receptor antagonist in rats with cyclosporine-induced hypertension","volume":"26","author":"Takeda","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.11.029_bib0300","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1111\/bph.13199","article-title":"Endothelin ETA receptor\/lipid peroxides\/COX-2\/TGF-beta1 signalling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats","volume":"172","author":"Helmy","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0305","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.taap.2014.01.008","article-title":"Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-beta1\/IL-2\/COX-2\/endothelin ET(B) receptor cascade","volume":"275","author":"El-Gowelli","year":"2014","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0310","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1590\/S0100-879X2004000700006","article-title":"Effect of cyclooxygenase inhibitors on gentamicin-induced nephrotoxicity in rats","volume":"37","author":"Hosaka","year":"2004","journal-title":"Braz. J. Med. Biol. Res.=Revista Brasileira de Pesquisas Medicas e Biologicas"},{"key":"10.1016\/j.phrs.2017.11.029_bib0315","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of calcineurin inhibitor-induced hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J. Nephrol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0320","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/01.HYP.0000085195.38870.44","article-title":"Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension","volume":"42","author":"Nishiyama","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.11.029_bib0325","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1046\/j.1523-1755.1999.00481.x","article-title":"Cyclosporine A up-regulates angiotensin II receptors and calcium responses in human vascular smooth muscle cells","volume":"55","author":"Avdonin","year":"1999","journal-title":"Kidney Int."},{"key":"10.1016\/j.phrs.2017.11.029_bib0330","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1056\/NEJM198402023100502","article-title":"Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin","volume":"310","author":"Ciabattoni","year":"1984","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.phrs.2017.11.029_bib0335","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1210\/jcem-56-6-1260","article-title":"Stimulation of renal prostaglandins by pressor hormones in man: comparison of prostaglandin E2 and prostacyclin (6 keto prostaglandin F1 alpha)","volume":"56","author":"Nadler","year":"1983","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.phrs.2017.11.029_bib0340","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/HYPERTENSIONAHA.113.03051","article-title":"Prostaglandin I2 and prostaglandin E2 modulate human intrarenal artery contractility through prostaglandin E2-EP4, prostacyclin-IP, and thromboxane A2-TP receptors","volume":"64","author":"Eskildsen","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.11.029_bib0345","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1161\/01.RES.86.6.663","article-title":"Biphasic actions of prostaglandin E2 on the renal afferent arteriole. Role of EP3 and EP4 receptors","volume":"86","author":"Tang","year":"2000","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0350","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.krcp.2015.10.004","article-title":"Physiology and pathophysiology of cyclooxygenase-2 and prostaglandin E2 in the kidney","volume":"34","author":"N\u00f8rregaard","year":"2015","journal-title":"Kidney Res. Clin. Pract."},{"key":"10.1016\/j.phrs.2017.11.029_bib0355","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/00007890-198806000-00026","article-title":"Effects of the prostaglandin E1 analog misoprostol on cyclosporine nephrotoxicity","volume":"45","author":"Paller","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2017.11.029_bib0360","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1681\/ASN.V1271359","article-title":"Endothelin-1 induces cyclooxygenase-2 expression via nuclear factor of activated T-cell transcription factor in glomerular mesangial cells","volume":"12","author":"Sugimoto","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0365","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1097\/01.ASN.0000031702.86799.B9","article-title":"Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney","volume":"13","author":"Hocherl","year":"2002","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0370","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejphar.2004.01.025","article-title":"Relative roles of endothelial relaxing factors in cyclosporine-induced impairment of cholinergic and beta-adrenergic renal vasodilations","volume":"487","author":"El-Mas","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0375","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/FJC.0b013e3181e74d83","article-title":"Role of PPAR gamma\/nitric oxide synthase signaling in the cyclosporine-induced attenuation of endothelium-dependent renovascular vasodilation","volume":"56","author":"Abd-Elrahman","year":"2010","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0380","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1097\/TP.0000000000001137","article-title":"Nox2 and cyclosporine-induced renal hypoxia","volume":"100","author":"Djamali","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2017.11.029_bib0385","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/01.HYP.23.6.957","article-title":"Cyclosporine produces endothelial dysfunction by increased production of superoxide","volume":"23","author":"Diederich","year":"1994","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.11.029_bib0390","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.freeradbiomed.2006.11.008","article-title":"Role of peroxynitrite in endothelial damage mediated by Cyclosporine A","volume":"42","author":"Navarro-Antolin","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.phrs.2017.11.029_bib0395","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1681\/ASN.V281291","article-title":"Chronic cyclosporine therapy impairs endothelium-dependent relaxation in the renal artery of the rat","volume":"2","author":"Diederich","year":"1992","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0400","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0014-2999(03)01720-5","article-title":"Testosterone depletion contributes to cyclosporine-induced chronic impairment of acetylcholine renovascular relaxations","volume":"468","author":"El-Mas","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0405","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ejphar.2017.04.016","article-title":"Modulation by NADPH oxidase of the chronic cardiovascular and autonomic interaction between cyclosporine and NSAIDs in female rats","volume":"806","author":"El-Yazbi","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0410","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.taap.2017.09.007","article-title":"CYP4A\/CYP2C modulation of the interaction of calcium channel blockers with cyclosporine on EDHF-mediated renal vasodilations in rats","volume":"334","author":"Hammoud","year":"2017","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0415","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1097\/FJC.0b013e31821ed803","article-title":"PPARgamma dependence of cyclosporine-isoprenaline renovascular interaction: roles of nitric oxide synthase and heme oxygenase","volume":"58","author":"El-Gowelli","year":"2011","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0420","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1440-1681.2008.04983.x","article-title":"Exacerbation by nicotine of the cyclosporine A-induced impairment of beta-adrenoceptor-mediated renal vasodilation in rats","volume":"35","author":"El-Gowilly","year":"2008","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0425","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1097\/00005344-200404000-00012","article-title":"Regional and endothelial differences in cyclosporine attenuation of adenosine receptor-mediated vasorelaxations","volume":"43","author":"El-Mas","year":"2004","journal-title":"J. Cardiovasc. Pharmacol."},{"issue":"1070.13","key":"10.1016\/j.phrs.2017.11.029_bib0430","article-title":"Heme oxygenase byproducts variably influences myocardial and autonomic dysfunctions induced by the cyclosporine\/diclofenac regimen in female rats","volume":"31","author":"Ibrahim","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2017.11.029_bib0435","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.bcp.2010.11.013","article-title":"Pioglitazone abrogates cyclosporine-evoked hypertension via rectifying abnormalities in vascular endothelial function","volume":"81","author":"El-Mas","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0440","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.bcp.2003.09.023","article-title":"Indomethacin-induced renal damage: role of oxygen free radicals","volume":"67","author":"Basivireddy","year":"2004","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0445","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1007\/s00204-005-0658-4","article-title":"Indomethacin induces free radical-mediated changes in renal brush border membranes","volume":"79","author":"Basivireddy","year":"2005","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0450","doi-asserted-by":"crossref","first-page":"lb541","DOI":"10.1096\/fasebj.31.1_supplement.lb541","article-title":"Enhanced lipoxygenase\/LTD4 activity accounts for the exaggerated hypertensive and nephrotoxic effects of cyclosporine plus indomethacin in rats","volume":"31","author":"Helmy","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2017.11.029_bib0455","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00041552-199509000-00013","article-title":"Hypertension after cardiac transplantation: pathophysiology and management","volume":"4","author":"Sander","year":"1995","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.phrs.2017.11.029_bib0460","doi-asserted-by":"crossref","first-page":"437","DOI":"10.2165\/00002018-199920050-00004","article-title":"Cyclosporin-induced hypertension: incidence, pathogenesis and management","volume":"20","author":"Taler","year":"1999","journal-title":"Drug Saf."},{"key":"10.1016\/j.phrs.2017.11.029_bib0465","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/ctr.12413","article-title":"Differential impact of belatacept and cyclosporine A on central aortic blood pressure and arterial stiffness after renal transplantation","volume":"28","author":"Seibert","year":"2014","journal-title":"Clin. Transplant."},{"key":"10.1016\/j.phrs.2017.11.029_bib0470","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007893.pub2","article-title":"Effect of cyclosporine on blood pressure","author":"Robert","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.phrs.2017.11.029_bib0475","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1016\/S0140-6736(06)69666-9","article-title":"Cardiovascular outcomes with etoricoxib and diclofenac in patients with osteoarthritis and rheumatoid arthritis in the Multinational Etoricoxib and Diclofenac Arthritis Long-term (MEDAL) programme: a randomised comparison","volume":"368","author":"Cannon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.phrs.2017.11.029_bib0480","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejphar.2014.01.034","article-title":"Blockade of endothelin ET(A), but not thromboxane, receptors offsets the cyclosporine-evoked hypertension and interrelated baroreflex and vascular dysfunctions","volume":"727","author":"Nasser","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0485","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00005344-200012000-00002","article-title":"Cyclosporine A and cremophor EL induce contractions of human saphenous vein: involvement of thromboxane A2 receptor-dependent pathway","volume":"36","author":"Hardy","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0490","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/sj.bjp.0701102","article-title":"Mechanism of enhanced vasoconstrictor hormone action in vascular smooth muscle cells by cyclosporin A","volume":"121","author":"Lo Russo","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0495","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2016.08.024","article-title":"Facilitation by the renin-angiotensin system of cyclosporine-evoked hypertension in rats: role of arterial baroreflexes and vasoreactivity","volume":"163","author":"Nasser","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2017.11.029_bib0500","doi-asserted-by":"crossref","first-page":"993","DOI":"10.17219\/acem\/37357","article-title":"The impact of combinations of non-steroidal anti-inflammatory drugs and anti-hypertensive agents on blood pressure","volume":"23","author":"Kalafutova","year":"2014","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.phrs.2017.11.029_bib0505","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/ndt\/gfm390","article-title":"Ciclosporin-induced hypertension is associated with increased sodium transporter of the loop of Henle (NKCC2)","volume":"22","author":"Esteva-Font","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.phrs.2017.11.029_bib0510","doi-asserted-by":"crossref","first-page":"F489","DOI":"10.1152\/ajprenal.00575.2016","article-title":"Calcineurin inhibitor cyclosporine A activates renal Na-K-Cl cotransporters via local and systemic mechanisms","volume":"312","author":"Blankenstein","year":"2017","journal-title":"Am. J. Physiol. Renal. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0515","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2369-11-28","article-title":"Increased renal sodium absorption by inhibition of prostaglandin synthesis during fasting in healthy man. A possible role of the epithelial sodium channels","volume":"11","author":"Lauridsen","year":"2010","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0520","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1023\/B:VERC.0000047507.85689.90","article-title":"Effects of cyclosporin A on blood pressure, baroreceptor reflex and renal function in dogs","volume":"29","author":"Ouisuwan","year":"2005","journal-title":"Vet. Res. Commun."},{"key":"10.1016\/j.phrs.2017.11.029_bib0525","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1124\/jpet.102.048447","article-title":"Cyclosporine induces progressive attenuation of baroreceptor heart rate response and cumulative pressor response in conscious unrestrained rats","volume":"305","author":"Shaltout","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.11.029_bib0530","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/01.HYP.35.6.1258","article-title":"Study of arterial and autonomic effects of cyclosporine in humans","volume":"35","author":"Lucini","year":"2000","journal-title":"Hypertension"},{"key":"10.1016\/j.phrs.2017.11.029_bib0535","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0167-5273(98)00368-4","article-title":"Cyclosporine A modulates baroreceptor function in kidney transplant recipients","volume":"68","author":"Gerhardt","year":"1999","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0540","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1536\/ihj.53.193","article-title":"Inhibition of oxidative stress in rostral ventrolateral medulla improves impaired baroreflex sensitivity in stroke-prone spontaneously hypertensive rats","volume":"53","author":"Ogawa","year":"2012","journal-title":"Int. Heart J."},{"key":"10.1016\/j.phrs.2017.11.029_bib0545","doi-asserted-by":"crossref","first-page":"R445","DOI":"10.1152\/ajpregu.1989.257.2.R445","article-title":"Prostaglandins in carotid sinus enhance baroreflex in rabbits","volume":"257","author":"McDowell","year":"1989","journal-title":"Am. J. Physiol.\u2014Regul. Integr. Compar. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0550","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/BF00265937","article-title":"Inhibition of cyclooxygenase attenuates baroreceptor function and increases the pressor response to norepinephrine in man","volume":"42","author":"Weisser","year":"1992","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0555","doi-asserted-by":"crossref","first-page":"H737","DOI":"10.1152\/ajpheart.00357.2004","article-title":"Cyclooxygenase inhibition and baroreflex sensitivity in humans","volume":"288","author":"Monahan","year":"2005","journal-title":"Am. J. Physiol.\u2014Heart Circ. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0560","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1113\/JP272944","article-title":"Increased sympathetic nerve activity and reduced cardiac baroreflex sensitivity in rheumatoid arthritis","volume":"595","author":"Adlan","year":"2017","journal-title":"J. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0565","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2015.01.018","article-title":"Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: role of endothelin signaling","volume":"284","author":"El-Mas","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0570","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/bcpt.12754","article-title":"Opposite modulatory effects of selective and non-selective cyclooxygenase inhibition on cardiovascular and autonomic consequences of cyclosporine in female rats","volume":"120","author":"Ibrahim","year":"2017","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0575","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.lfs.2017.07.019","article-title":"Role of NADPHox\/Rho-kinase signaling in the cyclosporine-NSAIDs interactions on blood pressure and baroreflexes in female rats","volume":"185","author":"El-Gowelli","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.phrs.2017.11.029_bib0580","doi-asserted-by":"crossref","first-page":"e000875","DOI":"10.1161\/JAHA.114.000875","article-title":"Cyclooxygenases 1 and 2 differentially regulate blood pressure and cerebrovascular responses to acute and chronic intermittent hypoxia: implications for sleep apnea","volume":"3","author":"Beaudin","year":"2014","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2017.11.029_bib0585","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1097\/01.hjh.0000244946.80287.3d","article-title":"Can the blood pressure effects of COX-2 selective inhibitors be explained by changes in plasma aldosterone levels","volume":"24","author":"Aw","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.phrs.2017.11.029_bib0590","first-page":"301","article-title":"Exploring cyclosporine A-side effects and the protective role-played by antioxidants: the morphological and immunohistochemical studies","volume":"21","author":"Rezzani","year":"2006","journal-title":"Histol. Histopathol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0595","first-page":"141","article-title":"Cardiovascular effects of cyclosporin treatment in an experimental model","volume":"21","author":"Tavares","year":"2002","journal-title":"Revista Portuguesa de Cardiologia=Portuguese J. Cardiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0600","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00408666","article-title":"Myocardial fibrosis and right ventricular function of heterotopically transplanted hearts in rats treated with cyclosporin","volume":"163\u2013164","author":"Kolar","year":"1996","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2017.11.029_bib0605","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0167-5273(91)90262-N","article-title":"Cyclosporine-associated reduction in systolic myocardial function in the rat","volume":"31","author":"Kingma","year":"1991","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0610","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0165-6147(00)01508-X","article-title":"Does cyclosporin A generate free radicals","volume":"21","author":"Buetler","year":"2001","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.phrs.2017.11.029_bib0615","first-page":"52","article-title":"Cyclosporin A induces cardiomyocyte injury through calcium-sensing receptor-mediated calcium overload","volume":"66","author":"Tang","year":"2011","journal-title":"Die Pharm."},{"key":"10.1016\/j.phrs.2017.11.029_bib0620","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11010-012-1336-5","article-title":"Cyclosporin A induces apoptosis in H9c2 cardiomyoblast cells through calcium-sensing receptor-mediated activation of the ERK MAPK and p38 MAPK pathways","volume":"367","author":"Chi","year":"2012","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.phrs.2017.11.029_bib0625","doi-asserted-by":"crossref","first-page":"R442","DOI":"10.1016\/j.cub.2005.06.006","article-title":"Calcineurin","volume":"15","author":"Hogan","year":"2005","journal-title":"Curr. Biol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0630","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s004150050360","article-title":"Cyclosporine neurotoxicity: a review","volume":"246","author":"Gijtenbeek","year":"1999","journal-title":"J. Neurol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0635","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2377-10-30","article-title":"Vasospasm is a significant factor in cyclosporine-induced neurotoxicity: case report","volume":"10","author":"Braakman","year":"2010","journal-title":"BMC Neurol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0640","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1124\/mi.4.2.7","article-title":"Biochemical mechanisms of cyclosporine neurotoxicity","volume":"4","author":"Serkova","year":"2004","journal-title":"Mol. Intervent."},{"key":"10.1016\/j.phrs.2017.11.029_bib0645","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjp.0704142","article-title":"Sirolimus, but not the structurally related RAD (everolimus), enhances the negative effects of cyclosporine on mitochondrial metabolism in the rat brain","volume":"133","author":"Serkova","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0650","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.005505","article-title":"Heart rate recovery and risk of cardiovascular events and all-cause mortality: a meta-analysis of prospective cohort studies","volume":"6","author":"Qiu","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.phrs.2017.11.029_bib0655","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ijcard.2016.08.233","article-title":"Diclofenac induces proteasome and mitochondrial dysfunction in murine cardiomyocytes and hearts","volume":"223","author":"Ghosh","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0660","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.yjmcc.2016.03.016","article-title":"Different effects of the nonsteroidal anti-inflammatory drugs meclofenamate sodium and naproxen sodium on proteasome activity in cardiac cells","volume":"94","author":"Ghosh","year":"2016","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0665","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1081\/DCT-120022645","article-title":"In vivo effects of meloxicam, celecoxib, and ibuprofen on free radical metabolism in human erythrocytes","volume":"26","author":"Burak Cimen","year":"2003","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0670","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000445681","article-title":"Swiss S1 guidelines on the systemic treatment of psoriasis vulgaris","volume":"232","author":"Kolios","year":"2016","journal-title":"Dermatol. (Basel, Switzerland)"},{"key":"10.1016\/j.phrs.2017.11.029_bib0675","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1152\/physrev.00041.2003","article-title":"Molecular regulation of vascular smooth muscle cell differentiation in development and disease","volume":"84","author":"Owens","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.phrs.2017.11.029_bib0680","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000250095","article-title":"Complex regulation and function of the inflammatory smooth muscle cell phenotype in atherosclerosis","volume":"47","author":"Orr","year":"2010","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0685","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/01.RES.0000216596.73005.3c","article-title":"Excitation-transcription coupling in arterial smooth muscle","volume":"98","author":"Wamhoff","year":"2006","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0690","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.mpmed.2010.05.002","article-title":"The pathogenesis of atherosclerosis","volume":"38","author":"Douglas","year":"2010","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.phrs.2017.11.029_bib0695","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.phymed.2015.10.016","article-title":"Anti-atherosclerotic plants which modulate the phenotype of vascular smooth muscle cells","volume":"23","author":"Saleh Al-Shehabi","year":"2016","journal-title":"Phytomedicine: Int. J. Phytother. Phytopharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0700","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1124\/jpet.109.163949","article-title":"Cyclosporine up-regulates Kruppel-like factor-4 (KLF4) in vascular smooth muscle cells and drives phenotypic modulation in vivo","volume":"333","author":"Garvey","year":"2010","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2017.11.029_bib0705","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1161\/CIRCRESAHA.108.186064","article-title":"Oxidized phospholipids induce type VIII collagen expression and vascular smooth muscle cell migration","volume":"104","author":"Cherepanova","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0710","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.1016\/S0041-1345(00)01542-6","article-title":"Effect of cyclosporine, mycophenolic acid, and rapamycin on the proliferation of rat aortic vascular smooth muscle cells: in vitro study","volume":"32","author":"Moon","year":"2000","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.phrs.2017.11.029_bib0715","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00007890-199802150-00003","article-title":"In vivo expression of transforming growth factor-\u03b21 in humans: stimulation by cyclosporine1","volume":"65","author":"Shin","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.phrs.2017.11.029_bib0720","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.cardiores.2007.02.022","article-title":"TGF-beta and atherosclerosis in man","volume":"74","author":"Grainger","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0725","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.1016\/j.bbamcr.2015.09.019","article-title":"The stellate vascular smooth muscle cell phenotype is induced by IL-1beta via the secretion of PGE2 and subsequent cAMP-dependent protein kinase A activation","volume":"1853","author":"Blirando","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2017.11.029_bib0730","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1165\/rcmb.2012-0262OC","article-title":"Reversal of myofibroblast differentiation by prostaglandin E(2)","volume":"48","author":"Garrison","year":"2013","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0735","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1002\/jcp.20673","article-title":"PGE2 amplifies the effects of IL-1beta on vascular smooth muscle cell de-differentiation: a consequence of the versatility of PGE2 receptors 3 due to the emerging expression of adenylyl cyclase 8","volume":"208","author":"Clement","year":"2006","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0740","doi-asserted-by":"crossref","first-page":"e69702","DOI":"10.1371\/journal.pone.0069702","article-title":"Prostacyclin and PPARalpha agonists control vascular smooth muscle cell apoptosis and phenotypic switch through distinct 14-3-3 isoforms","volume":"8","author":"Chen","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.11.029_bib0745","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1002\/jcp.23035","article-title":"Engineered endothelial progenitor cells that overexpress prostacyclin protect vascular cells","volume":"227","author":"Liu","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0750","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1161\/CIRCRESAHA.109.193656","article-title":"Shear stress induces synthetic-to-contractile phenotypic modulation in smooth muscle cells via peroxisome proliferator-activated receptor alpha\/delta activations by prostacyclin released by sheared endothelial cells","volume":"105","author":"Tsai","year":"2009","journal-title":"Circ. Res."},{"key":"10.1016\/j.phrs.2017.11.029_bib0755","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/FJC.0b013e318270b968","article-title":"Effectiveness of cyclooxygenase-2 inhibition in limiting abdominal aortic aneurysm progression in mice correlates with a differentiated smooth muscle cell phenotype","volume":"60","author":"Mukherjee","year":"2012","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.phrs.2017.11.029_bib0760","doi-asserted-by":"crossref","first-page":"e9800","DOI":"10.1371\/journal.pone.0009800","article-title":"Role of TGF-beta1 and MAP kinases in the antiproliferative effect of aspirin in human vascular smooth muscle cells","volume":"5","author":"Redondo","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2017.11.029_bib0765","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1161\/01.CIR.0000045664.75269.A5","article-title":"Acetylsalicylic acid inhibits cell proliferation by involving transforming growth factor-\u03b2","volume":"107","author":"Redondo","year":"2003","journal-title":"Circulation"}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817311763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661817311763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T02:00:48Z","timestamp":1719626448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661817311763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":153,"alternative-id":["S1043661817311763"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.029","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular and renal interactions between cyclosporine and NSAIDs: Underlying mechanisms and clinical relevance","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2017.11.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}